Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Nov-30-22 | Nov-30-21 | Nov-30-20 | Nov-30-19 | Nov-30-18 |
| 8-K | 10-K | 10-K | 10-K | S-1/A |
Total revenues [+] | 184.5 | 29.8 | 17.8 | 31.1 | 40.5 |
Royalties | 184.5 | | | | 40.5 |
Revenue growth | 520.2% | 66.9% | -42.7% | -23.2% | |
Cost of goods sold | 222.5 | 0.0 | 0.0 | 0.0 | 47.2 |
Gross profit | -38.0 | 29.8 | 17.8 | 31.1 | -6.7 |
Gross margin | -20.6% | 100.0% | 100.0% | 100.0% | -16.5% |
Selling, general and administrative [+] | 38.0 | 31.2 | 16.3 | 8.3 | 6.7 |
General and administrative | 38.0 | 31.2 | 16.3 | 8.3 | 6.7 |
Research and development | | 116.4 | 66.5 | 45.0 | |
Other operating expenses | 107.9 | | | | -3.6 |
EBITDA [+] | | -115.1 | -62.8 | -19.9 | -6.8 |
EBITDA growth | 59.8% | 83.3% | 215.9% | 194.5% | |
EBITDA margin | -99.7% | -386.9% | -352.4% | -63.9% | -16.7% |
Depreciation and amortization | | 2.8 | 2.2 | 2.4 | 3.0 |
EBIT [+] | -183.9 | -117.9 | -65.0 | -22.2 | -9.7 |
EBIT growth | 56.0% | 81.4% | 192.2% | 128.3% | |
EBIT margin | -99.7% | -396.3% | -364.7% | -71.5% | -24.0% |
Interest income | | 0.8 | 1.2 | 0.8 | 0.8 |
Interest income | | 0.8 | 1.2 | 0.8 | 0.8 |
Other income (expense), net | 3.5 | | | | |
Pre-tax income | -180.4 | -117.1 | -63.8 | -21.5 | -8.9 |
Income taxes | 0.0 | 0.1 | -20.5 | 0.2 | 0.5 |
Tax rate | 0.0% | | 32.2% | | |
Net income | -180.4 | -117.2 | -43.2 | -21.7 | -9.4 |
Net margin | -97.8% | -393.9% | -242.7% | -69.7% | -23.3% |
|
Basic EPS [+] | ($3.71) | ($2.73) | ($2.76) | ($6.59) | ($3.35) |
Growth | 35.8% | -1.0% | -58.1% | 96.9% | |
Diluted EPS [+] | ($3.71) | ($2.73) | ($2.76) | ($6.59) | ($3.35) |
Growth | 35.8% | -1.0% | -58.1% | 96.9% | |
|
Shares outstanding (basic) [+] | 48.6 | 42.9 | 15.7 | 3.3 | 2.8 |
Growth | 13.3% | 173.7% | 376.0% | 16.9% | |
Shares outstanding (diluted) [+] | 48.6 | 42.9 | 15.7 | 3.3 | 2.8 |
Growth | 13.3% | 173.7% | 376.0% | 16.9% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|